1.Induction factors of hypotension during cesarean section for perilous placenta previa under combined spinal-epidural anesthesia and construction of a nomogram prediction model
Weiwu LIU ; Weilan ZENG ; Xiuying XU ; Shuqiang ZHOU ; Miao LIANG ; Limei LIU ; Heng CHEN
Journal of Clinical Medicine in Practice 2024;28(20):66-71
Objective To investigate the induction factors of hypotension during cesarean section for perilous placenta previa under combined spinal-epidural anesthesia (CSEA) and to construct a nomogram prediction model. Methods A total of 130 parturients who underwent cesarean section for perilous placenta previa under CSEA from January 2020 to December 2023 in Yulin Maternity and Child Healthcare Hospital were selected as study subjects. A self-designed general information questionnaire was used to investigate the basic information and the occurrence of hypotension of the subjects. According to the occurrence of intraoperative hypotension, the patients were divided into hypotension group (47 cases) and non-hypotension group (83 cases). Univariate analysis was performed on the general information of the two groups, and multivariate Logistic regression analysis was used to explore the induction factors of intraoperative hypotension. Results Univariate analysis showed that there were statistically significant differences in body mass index, anesthesia level, presence of multiple pregnancy, preoperative systolic blood pressure, operative time, and the occurrence of Bezold-Jarisch reflex between the two groups (
2.A preliminary investigation on internal exposure dose of artificial radionuclides in nuclear medicine staff
Shuqiang YANG ; Xiaowen CHEN ; Meijia ZHAO ; Luqian ZHAO ; Hongran QIN ; Jingjing WANG ; Jiawei HE ; Xiaohua XU
Shanghai Journal of Preventive Medicine 2023;35(3):258-261
ObjectiveTo tentatively understand the status of radioactive contamination in nuclear medicine personnel. MethodsA total of 34 radiation staff engaged in nuclear medicine diagnosis and treatment were selected from two hospitals in Shanghai as the survey subjects.Among the 34 medical staff, 8 were nuclear medicine doctors, 14 were nuclear medicine technicians and 12 were nuclear medicine nurses. After surface contamination monitoring was first carried out to confirm that they had no surface radioactivity contamination, whole body scanning was performed with a whole body counter to determine whether they were internally contaminated with artificial radionuclides. ResultsThe α surface contamination was not detected in the nuclear medical staff. The β surface contamination of the nuclear medicine doctors, technicians and nurses was (13.8±0.8), (14.1±0.8) and (14.0±0.7) times per second, respectively. There were 2, 2, and 4 nuclear medicine doctors who were contaminated with 18F, 99mTc and 131I, 3, 5, and 2 nuclear medicine technicians who were contaminated with 18F, 99mTc and 131I, and 6, 8, and 5 nuclear medicine nurses who were contaminated with 18F, 99mTc and 131I, respectively. The 18F activity of nuclear medicine technicians was 1 997‒9 401 Bq, and the 99mTc activity of nuclear medicine technicians and nurses was 3 699‒18 692 and 652‒388 22 Bq, respectively. One nuclear medicine nurse had a 99mTc activity of 35 389 Bq. According to the preliminary estimation of 131I internal irradiation dose, the maximum committed effective dose of nuclear medicine doctors, technicians and nurses could reach 0.370, 0.018 and 0.584 mSv, respectively. ConclusionThe nuclear medicine staff are exposed to radioactive contamination, and it is important to monitor and evaluate their internal radiation doses.
3.Research progress of vision loss after botulinum toxin A injection
Xinxin LI ; Shuqiang WEI ; Xu MA
Chinese Journal of Plastic Surgery 2023;39(3):237-241
Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and, rarely, allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, this should also attract sufficient attention from clinicians. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.
4.Research progress of vision loss after botulinum toxin A injection
Xinxin LI ; Shuqiang WEI ; Xu MA
Chinese Journal of Plastic Surgery 2023;39(10):1162-1166
Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and rare allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, clinicians should pay enough attention on it. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.
5.Research progress of vision loss after botulinum toxin A injection
Xinxin LI ; Shuqiang WEI ; Xu MA
Chinese Journal of Plastic Surgery 2023;39(3):237-241
Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and, rarely, allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, this should also attract sufficient attention from clinicians. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.
6.Research progress of vision loss after botulinum toxin A injection
Xinxin LI ; Shuqiang WEI ; Xu MA
Chinese Journal of Plastic Surgery 2023;39(10):1162-1166
Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and rare allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, clinicians should pay enough attention on it. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.
7.Implementation of radiotherapy in a tertiary hospital in Zhejiang province during the epidemic of COVID-19
Tao SONG ; Hongen XU ; Qiang LI ; Min FANG ; Yongshi JIA ; Xiaodong LIANG ; Weijun CHEN ; Shuqiang WU ; Baihua LIN ; Mian YUAN
Chinese Journal of Radiological Medicine and Protection 2020;40(4):268-272
Objective:To explore the clinical practice of delivering radiotherapy during the outbreak of 2019 novel coronavirus disease(COVID-19).Methods:During this epidemic period, available method including but not limited to: strict disinfection, body temperature monitoring and staff training of relevant knowledge, were used to ensure the safety of radiotherapy treatment. Statistical analysis was performed to study the relevant data including proportion of patients receiving radiotherapy for different purposes, time from scanning to the first time of radiation delivery and degree of satisfaction in the view of staffs and patients, respectively.Results:A total of 60 patients received radiation therapy in the department of radiotherapy of Zhejiang Provincial People′s Hospital (2020-02-11). Compared with the same period in 2019 (after the Spring Festival), the total number of patients receiving radiotherapy was decreased from 72 to 60(83.3%). Among them, the number of patients receiving palliative radiation therapy decreased significantly, while the proportion of radical, preoperative and/or postoperative radiotherapy/radiochemotherapy did not significantly decrease. There was significant difference between two years ( χ2=6.967, P<0.05). The median time for newly admitted patients to receive radiotherapy was two days, which was not significantly longer than the interval in 2019 ( P>0.05). Staff and patients were generally satisfied with the current prevention measures. Conclusions:Using a variety of prevention and control method, and taking full account of medical safety and patient benefits, radiation-related activities can be carried out during the epidemic.
8. Implementation of radiotherapy in a tertiary hospital in Zhejiang province during the epidemic of COVID-19
Tao SONG ; Hongen XU ; Qiang LI ; Long CHEN ; Min FANG ; Yongshi JIA ; Xiaodong LIANG ; Weijun CHEN ; Shuqiang WU ; Baihua LIN ; Mian YUAN
Chinese Journal of Radiological Medicine and Protection 2020;40(0):E004-E004
Objective:
To explore the clinical practice of delivering radiotherapy during the outbreak of 2019 novel coronavirus disease(COVID-19).
Methods:
During this epidemic period, available methods including but not limited to: strict disinfection, body temperature monitoring, learning relevant knowledge by all staffs to ensure the safety of radiotherapy treatment. Relevant data including proportion of radiotherapy, time from scanning to the first time of radiation delivery and degree of satisfaction in the view of staffs and patients, respectively.
Results:
A total of 60 patients received radiation therapy in the department of radiotherapy of Zhejiang Provincial People’s Hospital (2020-02-11). Compared with the same period in 2019 (after the Spring Festival), the total number of patients receiving radiotherapy was decreased from 72 to 60(83.3%). Among them, the number of patients receiving palliative radiation therapy decreased significantly, while the proportion of radical, preoperative and/or postoperative radiotherapy/radiochemotherapy did not significantly decrease. There was significant difference between different years (
9.Huai qi huang granules for the treatment of children with mycoplasma pneumoniae pneumonia: a multicenter clinical study
Lishen SHAN ; Yunxiao SHANG ; Miao LI ; Xiaohua HAN ; Huanji CHENG ; Yan HUANG ; Jicheng DAI ; Shuqiang QU ; Jun SUN ; Yan BAI ; Changshan LIU ; Shaomin REN ; Yingchun LI ; Liping SUN ; Yingxue ZOU ; Hao XU ; Xiuqing WU ; Hong YAN ; Jing CHEN ; Li YAO ; Yanqi SU ; Chunmei JIA ; Chenghua SHI ; Jianhua LIU ; Zhongping ZHANG ; Jun WANG ; Yuling HAN ; Yanfen WANG ; Yushui WANG ; Guang YANG
International Journal of Pediatrics 2018;45(1):53-57,72
Objective To analyze the effects of Hual qi huang granules on children with mycoplasma pneumoniae pneumonia.Methods A randomized,multicenter parallel controlled clinical trial was carried out.A total of 3 000 cases of hospitalized children with mycoplasma pneumoniae pneumonia were selected.All of them were given treatment for mycoplasma pneumoniae pneumonia with macrolide antibiotics and symptomatic treatment.They were randomly divided into 2 groups:research group and control group.The children of research group were give oral Huai qi huang granules for three months.According to the classification of pneumonia,these two groups were divided into:lobar pneumonia research group,lobar pneumonia control group,lobular pneumonia research group,lobular pneumonia control group.The hospitalization duration of fever,length of hospital stay,the absorption area of lung inflammation and pneumonia severity sores were observed.The frequency of upper respiratory infections,bronchitis,pneumonia were observed in 3 months after discharge.Results 2 378 cases were investigated.The hospitalization duration of fever,length of hospital stay of research group were significantly shorter than that of in control group (P < 0.001).The children with lobar pneumonia,2 weeks after treatment,the absorption of consolidation of the lobar pneumonia research group is significantly better than lobar pneumonia control group (P <0.001).After two weeks treatment,the pneumonia scores of lobar pneumonia research group is lower than lobar pneumonia control group (P < 0.05).Followup of 3 months after hospital discharge,frequency of upper respiratory infection and bronchitis of research group,were significantly lower than that of control.In addition,appetite increased significantly in research group than control (P < 0.001).There are 21 cases with drug associated adverse reactions (mild diarrhea),including 12 cases of research group,9 cases of control group,and there was no statistical significance (P >0.05).Conclusion Standard treatment combined with oral Huai qi huang granules in the treatment of mycoplasma pneumoniae pneumonia,can significantly shorten hospitalization duration of fever,length of hospital stay and reduce the severity score of pneumonia.Three months oral Huai qi huang granules can significant reduce the frequency of respiratory infections and bronchitis,also can increase patients appetite,and be safe.
10.Effect of EZH2 on Hcy-induced cholesterol accumulation of foam cells
Yinju HAO ; Ning DING ; Shuqiang LI ; Lingbo XU ; Nan LI ; Yideng JIANG ; Xiaoling YANG
The Journal of Practical Medicine 2017;33(19):3176-3180
Objective To explore the effect of EZH2 on Hcy-induced cholesterol accumulation of foam cells. Methods THP-1 foam cells were divided into control group ,100 μmol/L Hcy group and folic acid group. Lipid droplet in foam cells was tested by Oil red O. TC and TG contents in cells were determined by enzymic meth od. H3K27me3 level and EZH2 protein expression were detected by Western-blot. EZH2 mRNA expression was assayed by q-PCR. H3K27me3 level and TC and TG contents were examined followed by overexpression or knock- down of EZH2. Results After administration of Hcy,TC and TG contents in foam cells were increased (P <0.05). H3K27me3 level and EZH2 expression were also increased(P<0.05). Overexpression of EZH2 caused the expansion of H3K27me3 level,and the TC and TC contents were also increased(P<0.05). Conclusion Regula-tion of H3K27me3 by EZH2 might be involved in Hcy-induced accumulation of cholesterol in foam cells.


Result Analysis
Print
Save
E-mail